(Reuters) – Drug distributor Cencora said on Wednesday it would acquire Retina Consultants of America (RCA) for $4.6 billion in cash, gaining access to its network of eye specialists.
The deal would add RCA’s nearly 300 retina specialists across 23 states to Cencora’s portfolio and expand its specialty medicines business.
Drug distributors have been boosting their presence in the market for specialty medicines, which treat complex conditions such as rheumatoid arthritis and cancer, eyeing their high profit margins and growing demand in the United States.
After the deal closes, Cencora said it would hold about 85% ownership in RCA.
(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)
